Litcius/Paper detail

Clostridium difficile toxins or infection induce upregulation of adenosine receptors and IL-6 with early pro-inflammatory and late anti-inflammatory pattern

Danielle Abreu Foschetti, Manuel B. Braga Neto, David T. Bolick, John H. Moore, Lara Gabriela Resende Dourado De Souza e Alves, CS. Martins, LE. Bomfin, AAQA. Santos, Renata Ferreira de Carvalho Leitão, Gerly Anne de Castro Brito, CA. Warren

2020Brazilian Journal of Medical and Biological Research15 citationsDOIOpen Access PDF

Abstract

Clostridium difficile causes intestinal inflammation, which increases adenosine. We compared the expression of adenosine receptors (AR) subtypes A1, A2A, A2B, and A3 in HCT-8, IEC-6 cells, and isolated intestinal epithelial cells, challenged or not with Clostridium difficile toxin A and B (TcdA and TcdB) or infection (CDI). In HCT-8, TcdB induced an early A2BR expression at 6 h and a late A2AR expression at 6 and 24 h. In addition, both TcdA and TcdB increased IL-6 expression at all time-points (peak at 6 h) and PSB603, an A2BR antagonist, decreased IL-6 expression and production. In isolated cecum epithelial cells, TcdA induced an early expression of A2BR at 2s and 6 h, followed by a late expression of A2AR at 6 and 24 h and of A1R at 24 h. In CDI, A2AR and A2BR expressions were increased at day 3, but not at day 7. ARs play a role in regulating inflammation during CDI by inducing an early pro-inflammatory and a late anti-inflammatory response. The timing of interventions with AR antagonist or agonists may be of relevance in treatment of CDI.

Topics & Concepts

MedicineClostridium difficile toxin AClostridium difficileAdenosine receptorInflammationAdenosineDownregulation and upregulationCecumReceptorClostridium difficile toxin BImmunologyMicrobiologyInternal medicinePharmacologyAgonistBiologyAntibioticsGeneBiochemistryClostridium difficile and Clostridium perfringens researchPediatric Pain Management TechniquesGastroesophageal reflux and treatments